Are vascular factors involved in glaucomatous damage?

Australian and New Zealand Journal of Ophthalmology

Volumn 27, Issue 5, 1999, Pages 354-357

  Graham, S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; NIFEDIPINE; NIMODIPINE;

BLOOD FLOW; BRAIN HEMORRHAGE; DISEASE ASSOCIATION; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MYOPIA; OPTIC NERVE; OPTIC NERVE DISEASE; SHORT SURVEY;

BLOOD VESSELS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OPTIC NERVE DISEASES;

EID: 0032729051     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1606.1999.00232.x     Document Type: Article

References (28)

1. Collaborative Normal Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressure. Am. J. Ophthalmol. 1998; 126: 487-97.
2. Cioffi GA. Three assumptions: ocular blood flow and glaucoma. J. Glaucoma 1999; 7: 299-300.
3. Drance SM. Disc haemorrhages in the glaucomas. Surv. Ophthalmol. 1989; 33: 331-7.
4. Jonas JB, Gusek GC, Naumann GOH. Die parapapillare Region in Normal- und Glaukom-augen. Klin. M.B.L. Augenheilk 1988; 183: 52-61.
5. Geijssen C. In: Local vascular risk factors. Studies on Normal Pressure Glaucoma. New York: Kugler Publications, 1991: 83-109.
6. Rader J, Feuer MS, Anderson DR. Peripapillary vasoconstriction in the glaucomas and anterior ischaemic optic neuropathy. Am. J. Ophthalmol. 1994; 117: 72-80.
7. Rankin SJA, Drance SM. Peripapillary retinal vasoconstriction in open angle glaucoma. J. Glaucoma 1996; 5: 22-8.
8. Jonas JB, Grundler AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open angle glaucoma. Graefe's Arch. Clin. Exp. Ophthalmol. 1998; 236: 202-6.
9. Drance S, Sweeney V, Morgan R, Feldman F. Studies of factors involved in the production of low tension glaucoma. Arch. Ophthalmol. 1973; 89: 457-65.
10. Kaiser HJ, Flammer J, Graf T, Stumpfig D. Systemic blood pressure in glaucoma patients. Graefe's Arch. Clin. Exp. Ophthalmol. 1993; 231: 677-80.
11. Leske MC, Conell AMS, Wu SY, Hyman LG, Schachat AP. Risk factors for open angle glaucoma. The Barbados Eye Study. Arch. Ophthalmol. 1995; 113: 918-24.
12. Leske MC, Pogdor MJ. Intraocular pressure, cardiovascular risk variables and visual field defects. Am. J. Epidemiol. 1983; 118: 280-87.
13. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch. Ophthalmol. 1995; 113: 216-21.
14. Graham SL, Drance SM, Wijsman K, Mikelberg FS, Douglas GR. Ambulatory blood pressure monitoring in glaucoma patients - The nocturnal dip. Ophthalmology 1995; 102: 61-9.
15. Hayreh S, Zimmerman M, Podhajsky B, Alward W. Nocturnal arterial hypotension and its role in optic nerve head ischaemic disorders. Am. J. Ophthalmol. 1994; 117: 603-24.
16. Drance SM, Douglas GR, Wijsman K, Schulzer M, Britton RJ. Response of blood flow to warm and cold in normal and low tension glaucoma patients. Am. J. Ophthalmol. 1988; 105: 35-9.
17. Pillunat LE, Lang GK, Harris A. The visual response to increased ocular blood flow in normal pressure glaucoma. Surv. Ophthalmol. 1994; 38 (Suppl.): S139-48.
18. Bose S, Piltz JR, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology 1995; 102: 1236-41.
19. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low tension glaucoma. Am. J. Ophthalmol. 1993; 115: 608-13.
20. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal tension glaucoma. J. Glaucoma 1998; 7: 372-7.
21. Carter C, Brooks D, Doyle D, Drance S. Investigations into a vascular etiology for low-tension glaucoma. Ophthalmology 1990; 97: 49-55.
22. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995; 102: 48-53.
23. Hayreh SS. Evaluation of optic nerve head circulation: review of the methods used. J. Glaucoma 1997; 6: 319-30.
24. Orgul S, Prunte C, Flammer J. Endothelium-derived vasoactive substances relevant to normal-tension glaucoma. Curr. Opin. Ophthalmol. 1988; 9: 88-94.
25. Miller KN, Quigley HA. The clinical appearance of the lamina cribrosa as a function of the extent of glaucomatous optic nerve damage. Ophthalmology 1988; 95: 135-8.
26. Yablonski ME, Asamoto A. Hypothesis concerning the pathophysiology of optic nerve damage in open angle glaucoma. J. Glaucoma 1993; 2: 119-27.
27. ARVO. Abstract no. 35555. Invest. Ophthalmol. Vis. Sci. 1999; 40: 5673.
28. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-34.